マーケットレポート詳細
変形性関節症治療：世界市場2026年予測
Osteoarthritis Therapeutics: Global Markets
- 出版元：BCC Research
出版元について - 発行年：2022年1月
- 定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文133ページになります。
- 商品コード：BCC363
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
変形性関節症治療薬の世界市場規模は2021年で74億ドル、2026年に112億ドル、市場の平均年成長率は8.6%で推移する見込みです。高齢者人口の増加、変形性関節症の罹患率の上昇、低侵襲手術の需要の増加が、変形性関節症治療薬市場の成長要因となっています。
当レポートでは、変形性関節症治療の市場および技術背景、COVID-19の影響、市場ダイナミクス、各種セグメント別市場分析(部位別、薬剤別、投与経路別、医薬品分類別、国地域別)、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
◆イントロダクション
・調査目的
・調査対象
・調査手法
◆サマリーと調査ハイライト
◆市場および技術背景
変形性関節症(OA)
・病因
・疫学/市場負担
・変形性関節症の有病率
・病気の症状
・危険因子
・診断
・治療
・OAにおける疼痛管理のためのNSAID
・変形性関節症のリスク軽減
◆COVID-19の影響
・概要
・変形性関節症とCOVID-19
・OA治療薬/ウイルス感染症
・結論
・企業の収益に対するCOVID-19の直接的な影響
◆市場ダイナミクス
・ドライバー
・障壁
・機会
・競合状況
◆部位別市場
・変形性膝関節症
・股関節変形性関節症
・その他
※組織別に地域別の細分化データ掲載-2026
◆薬剤タイプ別市場
・関節内ヒアルロン酸注射
・非ステロイド性抗炎症薬（NSAID）
・鎮痛薬
・コルチコステロイド
※薬剤タイプ別に地域別の細分化データ掲載-2026
◆投与経路別市場
・非経口
・経口
・局所
※投与経路別に地域別の細分化データ掲載-2026
◆医薬品分類別市場
・処方薬
・OTC
※薬剤分類別に地域別の細分化データ掲載-2026
◆国地域別市場
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア
・その他アジア太平洋
その他地域
※地域別に全セグメントの細分化データ掲載
◆主要企業プロフィール
ABBOTT LABORATORIES
ANIKA THERAPEUTICS INC.
BAYER AG
BIOVENTUS
ELI LILLY AND CO.
FERRING B.V.
FIDIA FARMACEUTICI S.P.A.
FLEXION THERAPEUTICS INC.
GLAXOSMITHKLINE PLC
HORIZON THERAPEUTICS PLC
JOHNSON & JOHNSON INC.
NOVARTIS AG
PFIZER INC.
SANOFI
生化学工業株式会社
(全133頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
Chapter 1 Introduction
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Osteoarthritis
- Etiology
- Epidemiology and Market Burden
- Prevalence of Osteoarthritis
- Disease Symptoms
- Risk Factors
- Diagnosis
- Treatment
- NSAIDs for Pain Management in OA
- Reducing the Risk of Osteoarthritis
Chapter 4 Impact of COVID-19
Overview
Osteoarthritis and COVID-19
- Predisposing Comorbidities in OA Patients
OA Drugs and Viral Infections
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Conclusion
Direct Impact of COVID-19 on Revenue of Companies
Chapter 5 Market Dynamics
Market Drivers
- Increasing Prevalence of Knee Osteoarthritis
- Increasing Population (Especially Elderly) Prone to Osteoarthritis, and an Increasing Number of Sports Injuries
- Significant Adoption of Pain Medications
Market Restraints
- The Risk of Adverse Cardiovascular Events Related to the Use of NSAIDs in Osteoarthritis
- Substitute Treatment Options
- Insurance Denials
- Government Regulations
Market Opportunities
- Personalized Medicines For OA
- Ongoing Research on Anti-(NGF) Nerve Growth Factor Therapy
- Patient Preference
- Strategic Initiatives
Competitive Landscape
Chapter 6 Market Breakdown by Anatomy
Global Market for Osteoarthritis Therapeutics by Anatomy
- Knee Osteoarthritis
- Hip Osteoarthritis
- Others
Chapter 7 Market Breakdown by Drug Type
Global Market for Osteoarthritis Therapeutics by Drug Type
- Viscosupplementation Agents
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Analgesics
- Corticosteroids
Chapter 8 Market Breakdown by Route of Administration
Global Market for Osteoarthritis Therapeutics by Route of Administration
- Parenteral Route
- Oral Route
- Topical Route
Chapter 9 Market Breakdown by Drug Classification (OTC/Prescription)
Global Market for Osteoarthritis Therapeutics by Drug Classification
- Prescription Drugs
- OTC
Chapter 10 Market Breakdown by Region
Global Market for Osteoarthritis Therapeutics Market by Region
North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 11 Company Profiles
ABBOTT LABORATORIES
ANIKA THERAPEUTICS INC.
BAYER AG
BIOVENTUS
ELI LILLY AND CO.
FERRING B.V.
FIDIA FARMACEUTICI S.P.A.
FLEXION THERAPEUTICS INC.
GLAXOSMITHKLINE PLC
HORIZON THERAPEUTICS PLC
JOHNSON & JOHNSON INC.
NOVARTIS AG
PFIZER INC.
SANOFI
SEIKAGAKU CORP.
Chapter 12 Appendix: List of Acronyms
List of Tables
Summary Table : Global Market for Osteoarthritis Therapeutics, by Anatomy, Through 2026
Table 1 : Classification of Common NSAIDs
Table 2 : Potential Role of OA drugs in COVID-19 Pandemic and Other Major Related Events
Table 3 : Global Market Ranking of Viscosupplementation Vendors, 2020
Table 4 : Global Market Ranking of OA Therapeutics Vendors, 2020
Table 5 : Global Market for Osteoarthritis Therapeutics, by Anatomy, Through 2026
Table 6 : Treatment Guidelines for Knee OA
Table 7 : Global Market for Knee Osteoarthritis Therapeutics, by Region, Through 2026
Table 8 : Global Market for Hip Osteoarthritis Therapeutics, by Region, Through 2026
Table 9 : Global Market for Other Types of Osteoarthritis Therapeutics (Shoulder, Hand, Small Joint), by Region, Through 2026
Table 10 : Global Market for Osteoarthritis Therapeutics, by Drug Type, Through 2026
Table 11 : Technical Characteristics of HA (Hyaluronic Acid) injection According to Joint
Table 12 : Global Market for Viscosupplementation Agents as Osteoarthritis Therapeutics, by Region, Through 2026
Table 13 : Global Market for NSAIDs as Osteoarthritis Therapeutics, by Region, Through 2026
Table 14 : Global Market for NSAIDs as Osteoarthritis Therapeutics, by Drug Type, Through 2026
Table 15 : Global Market for Analgesics as Osteoarthritis Therapeutics, by Region, Through 2026
Table 16 : Global Market for Corticosteroids as Osteoarthritis Therapeutics, by Region, Through 2026
Table 17 : Global Market for Osteoarthritis Therapeutics, by Route of Administration, Through 2026
Table 18 : Global Market for Osteoarthritis Therapeutics via the Parenteral Route, by Region, Through 2026
Table 19 : Global Market for Osteoarthritis Therapeutics via the Oral Route, by Region, Through 2026
Table 20 : Global Market for Osteoarthritis Therapeutics via the Topical Route, by Region, Through 2026
Table 21 : Global Market for Osteoarthritis Therapeutics, by Drug Classification, Through 2026
Table 22 : Global Market for Prescription Osteoarthritis Therapeutics, by Region, Through 2026
Table 23 : Global Market for OTC Osteoarthritis Therapeutics, by Region, Through 2026
Table 24 : Global Market for Osteoarthritis Therapeutics, by Region, Through 2026
Table 25 : North American Market for Osteoarthritis Therapeutics, by Anatomy, Through 2026
Table 26 : North American Market for Osteoarthritis Therapeutics, by Country, Through 2026
Table 27 : European Market for Osteoarthritis Therapeutics, by Anatomy, Through 2026
Table 28 : European Market for Osteoarthritis Therapeutics, by Country, Through 2026
Table 29 : Asia-Pacific Market for Osteoarthritis Therapeutics, by Anatomy, Through 2026
Table 30 : Asia-Pacific Market for Osteoarthritis Therapeutics, by Country, Through 2026
Table 31 : Rest of the World Market for Osteoarthritis Therapeuticss, by Anatomy, Through 2026
Table 32 : Abbott Laboratories: Products Offered
Table 33 : Anika Therapeutics Inc.: Products Offered
Table 34 : Anika Therapeutics Inc.: Recent Developments
Table 35 : Bayer AG: Products Offered
Table 36 : Bioventus: Products Offered
Table 37 : Bioventus: Recent Developments
Table 38 : Eli Lilly and Co.: Recent Developments
Table 39 : Ferring B.V.: Financials, 2019 and 2020
Table 40 : Ferring B.V.: Products Offered
Table 41 : Fidia Farmaceutici S.p.A.: Products Offered
Table 42 : Flexion Therapeutics Inc.: Products/Services Offered
Table 43 : Flexion Therapeutics Inc.: Recent Developments
Table 44 : GlaxoSmithKline PLC: Products Offered
Table 45 : GlaxoSmithKline PLC: Recent Developments
Table 46 : Horizon Therapeutics PLC: Product Portfolio Sales, 2020
Table 47 : Horizon Therapeutics PLC: Products Offered
Table 48 : Horizon Therapeutics PLC: Recent Developments
Table 49 : Johnson & Johnson Inc.: Products Offered
Table 50 : Johnson & Johnson Inc.: Recent Developments
Table 51 : Novartis AG: Products Offered
Table 52 : Novartis AG: Recent Developments
Table 53 : Pfizer Inc.: Products Offered
Table 54 : Pfizer Inc.: Recent Developments 2021
Table 55 : Sanofi: Products/Services Offered
Table 56 : Sanofi: Recent Developments
Table 57 : Seikagaku Corp.: Products/Services Offered
Table 58 : Seikagaku Corp.: Recent Developments
Table 59 : Acronyms Used in This Report
List of Figures
Summary Figure : Global Market Shares of Osteoarthritis Therapeutics, by Anatomy, 2020
Figure 1 : Global Market Shares of Osteoarthritis Therapeutics, by Anatomy, 2020
Figure 2 : Global Market for Knee Osteoarthritis Therapeutics, 2019-2026
Figure 3 : Global Market for Knee Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 4 : Global Market for Hip Osteoarthritis Therapeutics, 2019-2026
Figure 5 : Global Market for Hip Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 6 : Global Market for Other Types of Osteoarthritis Therapeutics (Shoulder, Hand, Small Joint), 2019-2026
Figure 7 : Global Market for Other Types of Osteoarthritis Therapeutics (Shoulder, Hand, Small Joint), by Region, 2019-2026
Figure 8 : Global Market Shares of Osteoarthritis Therapeutics by Drug Type, 2020
Figure 9 : Global Market for Viscosupplementation Agents as Osteoarthritis Therapeutics, 2019-2026
Figure 10 : Global Market for Viscosupplementation Agents as Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 11 : Global Market for NSAIDs as Osteoarthritis Therapeutics, 2019-2026
Figure 12 : Global Market for NSAIDs as Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 13 : Global Market Shares of NSAIDs as Osteoarthritis Therapeutics, by Drug Type, 2020
Figure 14 : Global Market for Analgesics as Osteoarthritis Therapeutics, 2019-2026
Figure 15 : Global Market for Analgesics as Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 16 : Global Market for Corticosteroids as Osteoarthritis Therapeutics, 2019-2026
Figure 17 : Global Market for Corticosteroids as Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 18 : Global Market Shares of Osteoarthritis Therapeutics, by Route of Administration, 2020
Figure 19 : Global Market for Osteoarthritis Therapeutics via the Parenteral Route, 2019-2026
Figure 20 : Global Market for Osteoarthritis Therapeutics via the Parenteral Route, by Region, 2019-2026
Figure 21 : Globa Market for Osteoarthritis Therapeutics via the Oral Route, 2019-2026
Figure 22 : Global Market for Osteoarthritis Therapeutics via the Oral Route, by Region, 2019-2026
Figure 23 : Global Market for Osteoarthritis Therapeutics via the Topical Route, 2019-2026
Figure 24 : Global Market for Osteoarthritis Therapeutics via the Topical Route, by Region, 2019-2026
Figure 25 : Global Market Shares of Osteoarthritis Therapeutics, by Drug Classification, 2020
Figure 26 : Global Market for Prescription Osteoarthritis Therapeutics, 2019-2026
Figure 27 : Global Market for Prescription Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 28 : Global Market for OTC Osteoarthritis Therapeutics, 2019-2026
Figure 29 : Global Market for OTC Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 30 : Global Market for Osteoarthritis Therapeutics, by Region, 2019-2026
Figure 31 : Global Market Shares of Osteoarthritis Therapeutics, by Region, 2020
Figure 32 : North American Market Shares of Osteoarthritis Therapeutics, by Anatomy, 2020
Figure 33 : North American Market Shares of Osteoarthritis Therapeutics, by Country, 2020
Figure 34 : U.S. Market for Osteoarthritis Therapeutics, 2019-2026
Figure 35 : Canadian Market for Osteoarthritis Therapeutics, 2020-2026
Figure 36 : European Market Shares of Osteoarthritis Therapeutics, by Anatomy, 2020
Figure 37 : European Market Shares of Osteoarthritis Therapeutics, by Country, 2020
Figure 38 : German Market for Osteoarthritis Therapeutics, 2019-2026
Figure 39 : French Market for Osteoarthritis Therapeutics, 2019-2026
Figure 40 : U.K. Market for Osteoarthritis Therapeutics, 2019-2026
Figure 41 : Italian Market for Osteoarthritis Therapeutics, 2019-2026
Figure 42 : Spanish Market for Osteoarthritis Therapeutics, 2019-2026
Figure 43 : Rest of European Market for Osteoarthritis Therapeutics, 2019-2026
Figure 44 : Asia-Pacific Market Shares of Osteoarthritis Therapeutics, by Anatomy, 2020
Figure 45 : Asia-Pacific Market Shares of Osteoarthritis Therapeutics, by Country, 2020
Figure 46 : Chinese Market for Osteoarthritis Therapeutics, 2019-2026
Figure 47 : Indian Market for Osteoarthritis Therapeutics, 2019-2026
Figure 48 : Japanese Market for Osteoarthritis Therapeutics, 2019-2026
Figure 49 : Australian Market for Osteoarthritis Therapeutics, 2019-2026
Figure 50 : Rest of Asia-Pacific Market for Osteoarthritis Therapeutics, 2019-2026
Figure 51 : Rest of the World Shares of Osteoarthritis Therapeutics, Market by Anatomy, 2020
Figure 52 : Abbott Laboratories: Net Revenue, 2016-2020
Figure 53 : Abbott Laboratories: Revenue Share, by Business Segment, 2020
Figure 54 : Abbott Laboratories: Revenue Share, by Region, 2020
Figure 55 : Anika Therapeutics Inc.: Net Revenue, 2016-2020
Figure 56 : Anika Therapeutics Inc.: Revenue Share, by Business Segment, 2020
Figure 57 : Anika Therapeutics Inc.: Revenue Share, by Region/Country, 2020
Figure 58 : Bayer AG: Net Revenue, 2016-2020
Figure 59 : Bayer AG: Revenue Share, by Business Segment, 2020
Figure 60 : Bayer AG: Revenue Share, by Region, 2020
Figure 61 : Bioventus: Net Revenue, 2018-2020
Figure 62 : Bioventus: Revenue Share, by Business Segment, 2020
Figure 63 : Bioventus: Revenue Share, by Region, 2020
Figure 64 : Eli Lilly and Co.: Net Revenue, 2016-2020
Figure 65 : Eli Lilly and Co.: Revenue Share, by Region, 2020
Figure 66 : GlaxoSmithKline PLC: Net Revenue, 2016-2020
Figure 67 : GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2020
Figure 68 : GlaxoSmithKline PLC: Revenue Share, by Region, 2021
Figure 69 : Horizon Therapeutics PLC: Net Revenue, 2016-2020
Figure 70 : Horizon Therapeutics PLC: Revenue Share, by Business Segment, 2020
Figure 71 : Horizon Therapeutics PLC: Revenue Share, by Region, 2021
Figure 72 : Horizon Therapeutics PLC: R&D Expenditure, 2016-2020
Figure 73 : Johnson & Johnson Inc.: Net Revenue, 2016-2020
Figure 74 : Johnson & Johnson Inc.: Revenue Share, by Business Segment, 2020
Figure 75 : Johnson & Johnson Inc.: Revenue Share, by Region/Country, 2021
Figure 76 : Novartis AG: Net Revenue, 2016-2020
Figure 77 : Novartis AG: Revenue Share, by Business Segment, 2020
Figure 78 : Novartis AG: Revenue Share, by Region/Country, 2021
Figure 79 : Pfizer Inc.: Net Revenue, 2016-2020
Figure 80 : Pfizer Inc.: Revenue Share, by Region/Country, 2021
Figure 81 : Sanofi: Net Revenue, 2016-2020
Figure 82 : Sanofi: Revenue Share, by Business Segment, 2020
Figure 83 : Sanofi: Revenue Share, by Region/Country, 2021
Figure 84 : Seikagaku Corp.: Net Revenue, 2016-2020
Figure 85 : Seikagaku Corp.: Revenue Share, by Business Segment, 2020